STARR KEVIN P

Director at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 2, 2006
Director at HUMAN GENOME SCIENCES INC · on record since Oct 20, 2006
Director at AGIOS PHARMACEUTICALS, INC. · on record since Jul 31, 2013
10% owner at EPOCH BIOSCIENCES INC · on record since Feb 13, 2014
Director at Larimar Therapeutics, Inc. · on record since Jun 26, 2014
10% owner at Larimar Therapeutics, Inc. · on record since Jun 26, 2014
10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Sep 12, 2014
10% owner at Blueprint Medicines Corp · on record since Apr 29, 2015
10% owner at FRANKLIN MULTI INCOME TRUST · on record since Apr 28, 2015
Director at Global Blood Therapeutics, Inc. · on record since Aug 19, 2015
10% owner at Global Blood Therapeutics, Inc. · on record since Aug 19, 2015
Director at MyoKardia, Inc. · on record since Oct 28, 2015
10% owner at MyoKardia, Inc. · on record since Oct 28, 2015
10% owner at CytomX Therapeutics, Inc. · on record since Oct 23, 2015
10% owner at Voyager Therapeutics, Inc. · on record since Nov 18, 2015
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at Jounce Therapeutics, Inc. · on record since Jan 26, 2017
10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 11, 2017
10% owner at · on record since Nov 6, 2017
10% owner at · on record since Jun 26, 2018
10% owner at · on record since Jul 24, 2018
10% owner at · on record since Jul 22, 2019
10% owner at · on record since Feb 18, 2020
10% owner at · on record since Jun 9, 2020
10% owner at · on record since Jul 29, 2020
10% owner at · on record since Jul 21, 2020
10% owner at · on record since Feb 12, 2021
Director at · on record since Jul 23, 2014
10% owner at · on record since Jul 23, 2014

Insider trading activity of STARR KEVIN P

Transactions on record: 194; since Jun 10, 2005

Open-market buys: 2; $2.3M

Open-market sells: 34; $152.3M

Companies traded: 14; last filing Jun 16, 2023

Figures computed from official regulatory filings — .

Companies where STARR KEVIN P has traded

45 tx · $38.9M · Jun 16, 2023
6 tx · $1.3M · Nov 12, 2021
6 tx · $17M · Jun 14, 2021
2 tx · $79.1K · Aug 24, 2018
16 tx · $71.4M · Mar 7, 2018
2 tx · $463.9K · Oct 19, 2017
58 tx · $18.5M · Jun 6, 2017
1 tx · $3M · Dec 21, 2016
6 tx · $1.7M · Dec 20, 2016
5 tx · $93.7K · Sep 7, 2016
2 tx · Nov 18, 2015
26 tx · $6M · Sep 25, 2015
16 tx · Feb 19, 2015
3 tx · $6.2K · Jul 12, 2007

Track record of STARR KEVIN P

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of STARR KEVIN P

Co-insiders of STARR KEVIN P

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sage Therapeutics, Inc.Listing unverified	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 17, 2022	AwardD (derivative)	9,947	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Nov 12, 2021	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC
Fulcrum Therapeutics, Inc.Listing on record	Sep 24, 2021	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 17, 2021	Buy	17,842	56.05 USD	$1M	conv 44ClusterFirst in 12mo	SEC
Jounce Therapeutics, Inc.Listing unverified	Jun 14, 2021	Other	-1,500,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 11, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jounce Therapeutics, Inc.Listing unverified	Mar 3, 2021	Sell	-1,450,000	11.75 USD	$17M		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 11, 2020	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	Other	5,595,238	—	n/a (No price was disclosed in the filing)		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	OtherD (derivative)	-39,166,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	Buy	81,250	16.00 USD	$1.3M	conv 44ClusterFirst in 12mo	SEC
Sage Therapeutics, Inc.Listing unverified	Jun 6, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Feb 14, 2019	Sell	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CONSTELLATION PHARMACEUTICALS INCListing unverified	Aug 24, 2018	OtherD (derivative)	-51,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CONSTELLATION PHARMACEUTICALS INCListing unverified	Aug 24, 2018	Other	51,032	1.55 USD	$79.1K		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 8, 2018	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Apr 19, 2018	Sell	-35,000	169.25 USD	$5.9M		SEC
Sage Therapeutics, Inc.Listing unverified	Apr 19, 2018	Sell	-24,000	168.28 USD	$4M		SEC
MyoKardia, Inc.Listing unverified	Mar 7, 2018	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Feb 20, 2018	Other	-510,554	—	n/a (No price was disclosed in the filing)		SEC
MyoKardia, Inc.Listing unverified	Jan 5, 2018	Sell	-816,326	42.00 USD	$34.3M	Unusual size	SEC
MyoKardia, Inc.Listing unverified	Dec 8, 2017	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
CytomX Therapeutics, Inc.Listing on record	Oct 19, 2017	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sage Therapeutics, Inc.Listing unverified	Jun 16, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 17, 2022	AwardD (derivative)	9,947	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Nov 12, 2021	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC
Fulcrum Therapeutics, Inc.Listing on record	Sep 24, 2021	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 17, 2021	Buy	17,842	56.05 USD	$1M	conv 44ClusterFirst in 12mo	SEC
Jounce Therapeutics, Inc.Listing unverified	Jun 14, 2021	Other	-1,500,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 11, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jounce Therapeutics, Inc.Listing unverified	Mar 3, 2021	Sell	-1,450,000	11.75 USD	$17M		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 11, 2020	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	Other	5,595,238	—	n/a (No price was disclosed in the filing)		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	OtherD (derivative)	-39,166,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jul 22, 2019	Buy	81,250	16.00 USD	$1.3M	conv 44ClusterFirst in 12mo	SEC
Sage Therapeutics, Inc.Listing unverified	Jun 6, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Feb 14, 2019	Sell	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CONSTELLATION PHARMACEUTICALS INCListing unverified	Aug 24, 2018	OtherD (derivative)	-51,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CONSTELLATION PHARMACEUTICALS INCListing unverified	Aug 24, 2018	Other	51,032	1.55 USD	$79.1K		SEC
Sage Therapeutics, Inc.Listing unverified	Jun 8, 2018	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sage Therapeutics, Inc.Listing unverified	Apr 19, 2018	Sell	-35,000	169.25 USD	$5.9M		SEC
Sage Therapeutics, Inc.Listing unverified	Apr 19, 2018	Sell	-24,000	168.28 USD	$4M		SEC
MyoKardia, Inc.Listing unverified	Mar 7, 2018	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Sage Therapeutics, Inc.Listing unverified	Feb 20, 2018	Other	-510,554	—	n/a (No price was disclosed in the filing)		SEC
MyoKardia, Inc.Listing unverified	Jan 5, 2018	Sell	-816,326	42.00 USD	$34.3M	Unusual size	SEC
MyoKardia, Inc.Listing unverified	Dec 8, 2017	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
CytomX Therapeutics, Inc.Listing on record	Oct 19, 2017	Other	-1,000,000	—	n/a (No price was disclosed in the filing)		SEC